G7/EC Funding Channels for HIV/AIDS Commitments, by Donor, 2006
(Excluding Funding for HIV/AIDS Research)
$2.63 B 2500 10%
Total Funding (in millions of US$)
2000
Global Fund*** Bilateral****
1500 90% 1000 $779.9 M 14% 500 86% $63.3 M 100%
Canada
$927.7 M
95% $90.7 M 83% $177.8 M $212.5 M 45% 73% 55%
Netherlands Sweden Other Governments
0
$184.8 M $206.8 M $173.5 M 81% 63% 71%
E.C** France Germany
$106.6 M $7.5 M
Italy
71% Japan**
U.K.
U.S.
Ireland
*This graph understates the U.S. commitment because it does not include significant U.S. funding for research in the area of HIV/AIDS. In FY 2006, the United States provided a total of $3.3 billion for global HIV/AIDS, TB, and HIV/AIDS research. If funding for global TB initiatives is excluded, but the funding for international HIV/AIDS research is included, U.S. appropriations for global HIV/AIDS were approximately $3.2 billion in FY 2006. ** Percentages represent the portion of a country’s HIV/AIDS commitments through the Global Fund or Bilateral Programs, respectively. Combined Bilateral and Global Fund percentages equal 100 for each country. Some countries’ percentages are omitted from the graph for lack of space. Those include Italy’s Bilateral contribution: 100%. *** Global Fund contributions are adjusted to represent estimated HIV/AIDS share based on Global Fund grant distribution by disease to date (58% for HIV/AIDS). **** U.S. commitment data represent reported obligations. Japan and U.K. data are preliminary estimates. U.K. disbursements used as proxy for commitments, pending further research. Netherlands data differ from HGIS annual reports, due to exclusion of TB and malaria funding, imputed multilateral finding, and indirect administrative costs. Source: Jennifer Kates, José-Antonio Izazola, and Eric Lief, “Financing the response to AIDS in low- and middle- income countries: International assistance from the G8, European Commission and other Donor Governments, 2006,” Kaiser Family Foundation and UNAIDS, June 2007.